Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Antidepressant Paroxetine Shows Potential To Treat HIV-Linked Cognitive Impairment
HIV-linked cognitive impairment may soon be treated with an antidepressant that can reverse the condition.
AstraZeneca agrees licensing deal for Plendil in China
AstraZeneca has struck a $500m deal to sell the marketing rights for two heart drugs, in the latest example of the UK pharmaceuticals group using licensing agreements to boost flagging revenues.
Potential Huntington's Disease Drug Found Effective In Mice, Monkeys: Study
TORONTO.
Glyphosate weed killer found in German beers, study finds
Fourteen beers popular in Germany contain traces of glyphosate, the world's most widely used weed killer, a Munich environmental group has said.
World's first Dengue vaccine out
Dengue is one of the most devastating mosquito borne diseases in the world.
FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide
PARIS, Feb.
Teva begins process of building new brand
JERUSALEM — Teva Pharmaceutical Industries announced Wednesday that it was starting the process of building a global brand via a corporate identity program that will span its enterprise.
Bayer Receives EU Approval of Kovaltry for Treatment of Hemophilia A
Leverkusen, February 22, 2016 – Bayer has received approval from the European Commission of Kovaltry® for the treatment of hemophilia A in patients of all age groups.
Japanese company produces fastest vaccines using tobacco leaves
Tokyo, Feb 23 (EFE).
OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer
TAIPEI, Taiwan, Feb.
Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association
HERTFORDSHIRE, England and PITTSBURGH, Feb.
Lannett Receives FDA Approval For Temozolomide Capsules
Lannett Company, Inc.
635
636
637
638
639
640
641
642
643
